Recent findings have strengthened the hypothesis that immunological dysfunc
tions may contribute towards the multifactorial pathogenesis of schizophren
ia. The validity of these findings is questioned by the fact that most stud
ied subjects have received potentially immunomodulatory medication upon inv
estigation. In order to rule out such confounding effects, 24 initially unm
edicated acutely ill schizophrenic patients were studied immunologically an
d psychiatrically (PANSS) before and during 4 weeks of neuroleptic treatmen
t. The production of IFN-gamma was decreased upon admission and after 2 wee
ks of treatment compared to matched healthy controls. No differences in IL-
2 and IFN-gamma production between unmedicated and medicated states were ob
served. These results do not support the notion that neuroleptic medication
in vivo might influence THI cytokine production in schizophrenia. NeuroRep
ort 11:3385-3388 (C) 2000 Lippincott Williams & Wilkins.